News and updates
Meet Robert Hills, our August volunteer of the month
Professor Robert Hills started volunteering for EHA when he participated in the Clinical Research Training in Hematology (CRTH) program in 2016. This year, Professor Hills started as an Associated Editor for HemaSphere. Meet Professor Hills and learn about what he does and why he's volunteering for EHA.
Anna Vardi Physician Scientist Research Grant winner 2018
Large-scale detection and characterization of T Cells with anti-tumor specificity in chronic lymphocytic leukemia: Can it pave the way for cellular treatments or vaccination strategies?
Meet our first Physician Scientist Research Grant winner
In 2018, the Physician Scientist Research Grant was awarded for the first time. During the 24th EHA Congress, Delfim Duarte from Porto, Portugal received the award. In a recent interview, Dr Duarte explains how he experienced the application procedure and describes the impact of winning this award.
Meet Shaun McCann, our July volunteer of the month
Professor Shaun McCann started volunteering for EHA since the start of the association and is still actively contributing. This year, Professor Shaun McCann was awarded the EHA Education and Mentoring Award. Meet Professor McCann and learn about what he's doing and why he's volunteering for EHA all these years!
Addressing the bureaucracy challenge
EHA has recently brought key stakeholders around the table to discuss bureaucratic obstacles in clinical research. Regulators, patient organizations, the European Commission and industry representatives were invited for a day-long discussion at EHA offices, building on an informal dialogue with the European Medicines Agency (EMA) that had been initiated by a group of prominent clinical researchers.
FUNDING ALERT: Calls published on ATMPs, T cells and cancer research
In recent weeks, two Calls for proposals were published that offer relevant funding opportunities for hematologists: IMI2 – 18th Call for proposals, a jointly funded partnership between the European Union, and Horizon 2020 – Call for cancer research proposals, call for research proposals in the category ‘Societal Challenge 1 (SC1): Health, demographic change and wellbeing’. .
Current status of the Clinical Trials Regulation
In 2014 the European Parliament approved the Clinical Trials Regulation (CTR) that is supposed to replace the Clinical Trials Directive (CTD) from 2001. Five years later, the regulation has not yet become applicable. What is the aim of the ‘new’ regulation, what issues does it address, and why was its application delayed?
EU Elections and Health Policy
2019 will see significant changes within the European institutions. The first already took place in late May, as 50% of EU citizens – the highest turnout since 1994 – went to the ballot box to elect their Members of the European Parliament (MEPs). The result: Confirmation that nationalism and Euroscepticism are on the rise, and a set-back of center political parties.
EHA congratulates the Spanish Society of Hematology on its 60th anniversary
EHA President, John Gribben and member of the SEHH, María Victoria Mateos
EHA24, another successful congress
More than 12,000 hematology professionals from around the world met together in Amsterdam, The Netherlands for the 24th European Hematology Association (EHA) Congress.
Meet Ton Hagenbeek, our May volunteer of the month
He started at EHA in the early days when it was still being run by a small office in Rotterdam. Now, EHA has grown and he's still with us. Meet Ton Hagenbeek and learn about what he's doing for EHA and why he has been volunteering through out all these years!
Challenges and opportunities in the diagnostics and management of onco-hematolog...
Onco-hematology was the focus of the two-day EHA Hematology Tutorial in Moscow, Russia, the third joint tutorial organized by EHA, the National Hematological Society (NHS) and the Russian-Oncohematology Society (ROHS). The first edition was held in 2013 in St Petersburg, the second in Moscow in 2016 and now in Moscow again.
Rolling out CAR T across Europe
Patient-centric treatments such as gene and cell therapies have been a game-changer in tackling hematological disorders. Nonetheless, their development remains slow and erratic, limiting benefit for patients.
Tackling Sickle Cell Disease: the need for a European approach
Learning how to recognize and treat a disease that is relatively new to many parts of Europe, and spreading, is crucial to limit, if not avoid, irreversible impact and provide proper care to patients.
Turkey tutorial focused on lymphoma
The 8th EHA-TSH Hematology Tutorial was held on April 6-7, 2019 in Izmir, Turkey. This marks yet another pleasant and fruitful collaboration between EHA and the Turkish Society of Hematology. This time, the tutorial focused on the topic of lymphoma and was chaired by Prof Anton Hagenbeek (NL) on behalf of EHA, and Prof Guner Hayri Özsan (TU) on behalf of TSH.